Technical Analysis for MRNA - Moderna, Inc.

Grade Last Price % Change Price Change
C 149.71 7.40% 10.31
MRNA closed up 7.4 percent on Tuesday, April 13, 2021, on 1.47 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical MRNA trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.40%
20 DMA Support Bullish 7.40%
Multiple of Ten Bearish Other 7.40%
Inside Day Range Contraction 7.40%
Older End-of-Day Signals for MRNA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits about 2 hours ago
Possible Pocket Pivot about 8 hours ago
50 DMA Resistance about 10 hours ago
Rose Above 50 DMA about 12 hours ago
3x Volume Pace about 12 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Coronavirus Vaccine Cancer Vaccine RNA Cancer Vaccines Messenger RNA

Is MRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 189.26
52 Week Low 36.62
Average Volume 9,057,374
200-Day Moving Average 105.25
50-Day Moving Average 148.78
20-Day Moving Average 136.67
10-Day Moving Average 134.08
Average True Range 9.01
ADX 14.24
+DI 30.96
-DI 18.66
Chandelier Exit (Long, 3 ATRs ) 130.71
Chandelier Exit (Short, 3 ATRs ) 144.37
Upper Bollinger Band 154.19
Lower Bollinger Band 119.14
Percent B (%b) 0.87
BandWidth 25.64
MACD Line -1.13
MACD Signal Line -3.42
MACD Histogram 2.2919
Fundamentals Value
Market Cap 59.24 Billion
Num Shares 396 Million
EPS -2.35
Price-to-Earnings (P/E) Ratio -63.76
Price-to-Sales 233.14
Price-to-Book 22.55
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 159.85
Resistance 3 (R3) 159.52 155.82 158.16
Resistance 2 (R2) 155.82 153.23 155.98 157.60
Resistance 1 (R1) 152.76 151.64 154.29 153.09 157.03
Pivot Point 149.06 149.06 149.82 149.22 149.06
Support 1 (S1) 146.00 146.47 147.53 146.33 142.39
Support 2 (S2) 142.30 144.88 142.46 141.82
Support 3 (S3) 139.24 142.30 141.26
Support 4 (S4) 139.57